Spots Global Cancer Trial Database for adolescents
Every month we try and update this database with for adolescents cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| An Exploratory Study of the Use of Five Wishes as a Tool for Advanced Care Planning in Young Adults With Metastatic, Recurrent, or Progressive Cancer or HIV Infection | NCT01445145 | Neoplasms | 16 Years - 30 Years | National Institutes of Health Clinical Center (CC) | ||
| Lived Experiences of Adolescents in the Treatment Process of Cancer and the Impact on Occupations | NCT00456209 | Pediatric Cance... | 13 Years - 19 Years | Hackensack Meridian Health | ||
| Effectiveness of the Q-HPV Vaccine 9-years Post Vaccination Among HIV Positive Adolescents | NCT05435209 | HPV Infection HPV Vaccination | Quadrivalent Hu... | 16 Years - 25 Years | University of Washington | |
| MOST EMPOWER: Optimizing An Emotion Regulation Intervention | NCT04317417 | Cancer | EMPOWER | 15 Years - 39 Years | Wake Forest University Health Sciences | |
| Feasibility and Acceptability of a Virtual 'Coping With Brain Fog' Intervention for Young Adults With Cancer | NCT05115422 | Cancer Cognitive Dysfu... Cognitive Impai... Adolescents Young Adults | 'Coping with Br... | 18 Years - 40 Years | University of Manitoba | |
| Strength and Nutrition Outcomes for Latino Adolescents | NCT00697580 | Obesity Type 2 Diabetes Cardiovascular ... Cancer | Nutrition Strength Traini... Circuit Trainin... | 14 Years - 18 Years | University of Southern California | |
| Strength Training and Nutrition Development for African American Youth | NCT01441323 | Obesity Type 2 Diabetes Cardiovascular ... Cancer | Nutrition Strength Traini... | 14 Years - 18 Years | University of Southern California | |
| COVID-19 in Immunosuppressed Children | NCT04511429 | Infections, Cor... Kidney Transpla... Liver Transplan... Cancer Covid19 | 1 Month - 18 Years | D'Or Institute for Research and Education | ||
| Improving Care Coordination for Adolescents and Young Adults With Cancer | NCT04586127 | Cancer | AYA NA-SB Quest... | 18 Years - 39 Years | Wake Forest University Health Sciences | |
| Pilot Study Combining Temozolomide, Oncovin, Camptosar and Oral Antibiotic in Children and Adolescents With Recurrent Malignancy | NCT00222443 | Lymphomas Tumors | Irinotecan | 1 Year - 21 Years | University of Oklahoma | |
| COVID-19 in Immunosuppressed Children | NCT04511429 | Infections, Cor... Kidney Transpla... Liver Transplan... Cancer Covid19 | 1 Month - 18 Years | D'Or Institute for Research and Education | ||
| Study Of Vinblastine in Combination With Nilotinib in Children, Adolescents and Young Adults | NCT01884922 | Refractory Low-... Recurrent Low-g... | Nilotinib Vinblastine | 6 Months - 20 Years | Gustave Roussy, Cancer Campus, Grand Paris | |
| Effect of Metformin on ABCB1 and AMPK Expression in Adolescents With Newly Diagnosed Acute Lymphoblastic Leukemia | NCT05326984 | Acute Lymphobla... | Metformin | 10 Years - 21 Years | Hospital General de Mexico | |
| Effects of Metformin and Oral Hormonal Contraceptive in Adolescents With Polycystic Ovary Syndrome | NCT00988078 | Polycystic Ovar... | Placebo Metformin | 11 Years - 19 Years | Federal University of São Paulo | |
| Study of Vinblastine in Combination With Nilotinib in Children, Adolescents, and Young Adults | NCT01887522 | Refractory Low-... Recurrent Low-g... | Vinblastine + N... Vinblastine | 6 Months - 20 Years | Gustave Roussy, Cancer Campus, Grand Paris | |
| Feasibility and Acceptability of a Virtual 'Coping With Brain Fog' Intervention for Young Adults With Cancer | NCT05115422 | Cancer Cognitive Dysfu... Cognitive Impai... Adolescents Young Adults | 'Coping with Br... | 18 Years - 40 Years | University of Manitoba | |
| Shanghai Epidemiology Study for Adolescents and Children With Cancer | NCT02959086 | Childhood Cance... | 0 Years - 19 Years | Children's Cancer Group, China | ||
| Theca Cell Function in Adolescents With Polycystic Ovary Syndrome (PCOS) | NCT01154192 | PCOS | Dexamethasone recombinant hum... | 12 Years - 18 Years | University of California, San Diego | |
| Adolescent Polycystic Ovary Syndrome on a Low-carbohydrate Diet | NCT06429618 | Polycystic Ovar... Adolescent Beha... Diet Habit | Low carbonhydra... | 12 Years - 24 Years | Etlik Zubeyde Hanım Women's Health Care, Training and Research Hospital | |
| Strength and Nutrition Outcomes for Latino Adolescents | NCT00697580 | Obesity Type 2 Diabetes Cardiovascular ... Cancer | Nutrition Strength Traini... Circuit Trainin... | 14 Years - 18 Years | University of Southern California | |
| A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Conjugate Vaccine In Adolescents | NCT00518180 | Meningococcal M... Human Papilloma... Pertussis Tetanus | Novartis Mening... Tdap Vaccine Novartis Mening... | 11 Years - 18 Years | Novartis | |
| Feasibility and Acceptability of a Virtual 'Coping With Brain Fog' Intervention for Young Adults With Cancer | NCT05115422 | Cancer Cognitive Dysfu... Cognitive Impai... Adolescents Young Adults | 'Coping with Br... | 18 Years - 40 Years | University of Manitoba | |
| Study Of Vinblastine in Combination With Nilotinib in Children, Adolescents and Young Adults | NCT01884922 | Refractory Low-... Recurrent Low-g... | Nilotinib Vinblastine | 6 Months - 20 Years | Gustave Roussy, Cancer Campus, Grand Paris | |
| Needs Navigation for Caregivers of AYAs | NCT06296641 | Cancer in Adole... | Needs navigatio... | 15 Years - 26 Years | Columbia University | |
| Selenium in the Treatment of Complicated Lymphatic Malformations | NCT01212965 | Lymphatic Malfo... | Selenium | 14 Years - 30 Years | Medical College of Wisconsin | |
| Effect of Metformin on ABCB1 and AMPK Expression in Adolescents With Newly Diagnosed Acute Lymphoblastic Leukemia | NCT05326984 | Acute Lymphobla... | Metformin | 10 Years - 21 Years | Hospital General de Mexico | |
| Study Of Vinblastine in Combination With Nilotinib in Children, Adolescents and Young Adults | NCT01884922 | Refractory Low-... Recurrent Low-g... | Nilotinib Vinblastine | 6 Months - 20 Years | Gustave Roussy, Cancer Campus, Grand Paris | |
| Improving Symptom Self-management in Adolescents & Young Adults With Cancer | NCT02974569 | Symptom Cluster... Cancer | Computer Sympto... | 15 Years - 29 Years | Virginia Commonwealth University | |
| Efficacy/Safety Study of ACTIQ® for Opioid-Tolerant Children and Adolescents With Breakthrough Pain (BTP) | NCT00236041 | Cancer Breakthrough Pa... | ACTIQ® | 3 Years - 15 Years | Teva Branded Pharmaceutical Products R&D, Inc. | |
| SDH of HPV Vaccine Completion | NCT03709602 | Human Papilloma... | - | Duke University | ||
| The Pain Squad+ Smartphone App To Support Real-Time Pain Management for Adolescents With Cancer | NCT03632343 | Therapy-Associa... | Pain Squad+ wit... Pain Squad+ | 12 Years - 18 Years | The Hospital for Sick Children | |
| Biological Medicine for Diffuse Intrinsic Pontine Glioma (DIPG) Eradication 2.0 | NCT05476939 | Diffuse Intrins... Diffuse Midline... | Everolimus ONC201 Radiotherapy | 6 Months - | Gustave Roussy, Cancer Campus, Grand Paris | |
| Pilot Study Combining Temozolomide, Oncovin, Camptosar and Oral Antibiotic in Children and Adolescents With Recurrent Malignancy | NCT00222443 | Lymphomas Tumors | Irinotecan | 1 Year - 21 Years | University of Oklahoma | |
| Shanghai Epidemiology Study for Adolescents and Children With Cancer | NCT02959086 | Childhood Cance... | 0 Years - 19 Years | Children's Cancer Group, China | ||
| The Pain Squad+ Smartphone App To Support Real-Time Pain Management for Adolescents With Cancer | NCT03632343 | Therapy-Associa... | Pain Squad+ wit... Pain Squad+ | 12 Years - 18 Years | The Hospital for Sick Children | |
| Strength and Nutrition Outcomes for Latino Adolescents | NCT00697580 | Obesity Type 2 Diabetes Cardiovascular ... Cancer | Nutrition Strength Traini... Circuit Trainin... | 14 Years - 18 Years | University of Southern California | |
| Targeted Immunotherapy After Myeloablative TBI-Based Conditioning & AlloHCT in CAYA With High Risk T-Cell ALL & Lymphoma | NCT04972942 | T-cell Acute Ly... T-Cell Acute Ly... | Daratumumab | - 39 Years | New York Medical College | |
| Energy Balance & Weight Loss in Craniopharyngioma-related or Other Hypothalamic Tumors in Hypothalamic Obesity | NCT02664441 | Hypothalamic Ob... | Exenatide placebo | 10 Years - 25 Years | Seattle Children's Hospital | |
| Allogeneic Stem Cell Transplantation in Children and Adolescents With Acute Lymphoblastic Leukaemia | NCT01423747 | Lymphoblastic L... | VP16 TBI VP16, ATG TBI Fludarabine, OK... VP16, ATG TBI | 3 Months - 18 Years | St. Anna Kinderkrebsforschung | |
| Testing a School-Based E-cigarette, Tobacco, and Betel (Areca) Nut Use Prevention Curriculum for Guam Youths | NCT05037656 | Tobacco Smoking Vaping Tobacco Chewing | School-based cu... | 11 Years - 15 Years | University of Guam | |
| Preventing of GVHD With Post-transplantation Cyclophosphamide, Abatacept, Vedolizumab and Calcineurin Inhibitor at Patients With Hemoblastosis | NCT05515029 | Acute Lymphobla... Myeloblastic Le... Biphenotypic Ac... Malignant Lymph... Myelodysplastic... Juvenile Myelom... | GVHD prevention... | 1 Day - 21 Years | Federal Research Institute of Pediatric Hematology, Oncology and Immunology | |
| Metformin for Ectopic Fat Deposition and Metabolic Markers in Polycystic Ovary Syndrome (PCOS) | NCT02500147 | Polycystic Ovar... Non-Alcoholic F... Metabolic Syndr... | Metformin Placebo | 13 Years - 25 Years | Columbia University | |
| Metformin Treatment in Adolescent Patients With PCOS: A Long-term, Winning Metabolic Choice. | NCT06015594 | Polycystic Ovar... | Metformin | 10 Years - 19 Years | University of Cagliari | |
| Biological Medicine for Diffuse Intrinsic Pontine Glioma (DIPG) Eradication | NCT02233049 | Diffuse Intrins... | Erlotinib Everolimus Dasatinib | 6 Months - 25 Years | Gustave Roussy, Cancer Campus, Grand Paris | |
| ALL-SCT BFM International- HSCT in Children and Adolescents With ALL | NCT01423500 | Lymphoblastic L... | VP16 TBI VP16, ATG TBI Fludarabine, OK... VP16, ATG TBI | 3 Months - 18 Years | St. Anna Kinderkrebsforschung | |
| NAFLD in Adolescents and Young Adults With PCOS | NCT02506946 | Polycystic Ovar... Non-Alcoholic F... Metabolic Syndr... | 14 Years - 25 Years | Columbia University | ||
| Development and Validation of the EFT for Adolescents With Cancer | NCT05304988 | Cancer | Testing of the ... | 13 Years - 18 Years | The Hong Kong Polytechnic University | |
| Playful Sensorimotor Training in Pediatric Brain Tumor Patients | NCT03334162 | Pediatric Cance... Pediatric Brain... Chemotherapy-in... Sensorimotor Po... | Sensorimotor tr... | 6 Years - 18 Years | University of Basel | |
| Biological Medicine for Diffuse Intrinsic Pontine Glioma (DIPG) Eradication | NCT02233049 | Diffuse Intrins... | Erlotinib Everolimus Dasatinib | 6 Months - 25 Years | Gustave Roussy, Cancer Campus, Grand Paris | |
| Safety Study of the Repeated Opening of the Blood-brain Barrier With the SonoCloud® Device to Treat Malignant Brain Tumors in Pediatric Patients | NCT05293197 | Malignant Brain... Malignant Gliom... Embryonal Tumor | SonoCloud® (9 t... | 5 Years - 17 Years | Assistance Publique - Hôpitaux de Paris | |
| Biological Medicine for Diffuse Intrinsic Pontine Glioma (DIPG) Eradication 2.0 | NCT05476939 | Diffuse Intrins... Diffuse Midline... | Everolimus ONC201 Radiotherapy | 6 Months - | Gustave Roussy, Cancer Campus, Grand Paris | |
| Shadow for All, a Citizenship Science Study to Promote the Prevention of Skin Cancer | NCT06145464 | Skin Cancer | Adhesion to the... Adhesion to the... Adhesion to the... Adhesion to the... | 14 Years - | Universidade do Porto | |
| Preventing of GVHD With Post-transplantation Cyclophosphamide, Abatacept, Vedolizumab and Calcineurin Inhibitor at Patients With Hemoblastosis | NCT05515029 | Acute Lymphobla... Myeloblastic Le... Biphenotypic Ac... Malignant Lymph... Myelodysplastic... Juvenile Myelom... | GVHD prevention... | 1 Day - 21 Years | Federal Research Institute of Pediatric Hematology, Oncology and Immunology | |
| A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Conjugate Vaccine In Adolescents | NCT00518180 | Meningococcal M... Human Papilloma... Pertussis Tetanus | Novartis Mening... Tdap Vaccine Novartis Mening... | 11 Years - 18 Years | Novartis |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
